31 citations
,
January 2016 in “Drugs - Real World Outcomes” This review discusses the potential link between direct oral anticoagulants and hair loss, suggesting DOACs may not be a suitable alternative for patients with alopecia from traditional anticoagulants; however, no clinical results are reported.
7 citations
,
May 2017 in “Research and Practice in Thrombosis and Haemostasis” This case report observed that a 20-year-old female with recurrent DVTs experienced reversible alopecia with various anticoagulants, except fondaparinux which allowed long-term treatment without this side effect.
March 2026 in “Frontiers in Pharmacology” The study concluded that the Exprecell™ device for preparing anticoagulant-free f-PRF increases volume yield and simplifies the process while maintaining biological activity comparable to conventional methods, suggesting potential clinical utility.
January 2020 in “Jornal Vascular Brasileiro” This review discusses the mechanisms behind alopecia during anticoagulation therapy and current treatments but reports no new clinical results.
1 citations
,
November 2011 in “InTech eBooks” This review discusses the challenges of anticoagulation in hemodialysis, including the limitations and risks of current methods, and emphasizes the need for better solutions, but reports no new clinical results.